APP and early-onset autosomal dominant Alzheimer disease: Gpc1 is unlikely to be the sole mechanism by which miR-324-5p exerts any effects on the nervous system, and in fact we found that miR-324-5p can also inhibit App expression (Fig. 4F); a gene whose protein contributes to brain pathogenesis, such as in Alzheimer's disease.